Your Unread Messages in Pharmacy
See All >> Messages include industry-sponsored communications and special communications from MDLinx
D Scott Cunningham MD, PhD
Site Editor, MDLinx
ASA as effective as sumatriptan in treatment of acute migraines
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
Clinical Pearls for Pain Managers and Prescribers
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
121 Multi-drug inhibition of the HER pathway in metastatic colorectal cancer: Results of a phase I study of pertuzumab plus cetuximab in cetuximab-refractory patients Investigational New Drugs, April 10, 2013 Clinical Article
122 Selective advantages of two major clones of carbapenem-resistant Pseudomonas aeruginosa isolates (CC235 and CC641) from Korea: antimicrobial resistance, virulence, and biofilm-forming activity Journal of Medical Microbiology, April 10, 2013 Review Article Clinical Article
123 Chemosensitivity Induced by Down-regulation of MicroRNA-21 in Gemcitabine-resistant Pancreatic Cancer Cells by Indole-3-Carbinol Anticancer Research, April 10, 2013 Clinical Article
124 Shugoshin1 enhances multidrug resistance of gastric cancer cells by regulating MRP1, Bcl-2, and Bax genes Tumor Biology, April 10, 2013 Clinical Article
125 TypA is involved in virulence, antimicrobial resistance and biofilm formation in Pseudomonas aeruginosa Full Text BMC Microbiology, April 10, 2013 Clinical Article
126 Effect of quercetin on the transport of N-acetyl 5-aminosalicylic acid Journal of Pharmacy and Pharmacology, April 10, 2013 Review Article
127 Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea Diagnostic Microbiology and Infectious Disease, April 9, 2013 Clinical Article
128 Use of Molecular Biomarkers to Quantify the Spatial Distribution of Effects of Anticancer Drugs in Solid Tumors Molecular Cancer Therapeutics, April 9, 2013 Clinical Article
129 Inhibition of HSP90 with AUY922 Induces Synergy in HER2-Amplified Trastuzumab-Resistant Breast and Gastric Cancer Molecular Cancer Therapeutics, April 9, 2013 Clinical Article
130 Chalcogenopyrylium Dyes as Differential Modulators of Organic Anion Transport by MRP1, MRP2 and MRP4 Drug Metabolism and Disposition, April 9, 2013 Review Article
131 Apigenin sensitizes doxorubicin-resistant hepatocellular carcinoma BEL-7402/ADM cells to doxorubicin via inhibiting PI3K/Akt/Nrf2 pathway Carcinogenesis, April 8, 2013 Clinical Article
132 Peroxiredoxin III protein expression is associated with platinum resistance in epithelial ovarian cancer Tumor Biology, April 8, 2013 Clinical Article
133 Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR mutations: an exploratory study Annals of Oncology, April 8, 2013 Clinical Article
134 Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung Cancers Clinical Cancer Research, April 8, 2013 Clinical Article
135 Acquisition of Chemo- or Radioresistance and Epithelial to Mesenchymal Transition (EMT) Phenotypes in Docetaxel-Resistant Lung Adenocarcinoma Cells was Linked with Downregulation of Let-7c Molecular Cancer Research, April 8, 2013 Clinical Article
136 A Re-evaluation of the Role of hCTR1, the Human High Affinity Cu Transporter in Pt-Drug Entry into Human Cells Molecular Pharmacology, April 8, 2013 Review Article
137 High abundance and diversity of antimicrobial resistance determinants among early vancomycin-resistant Enterococcus faecium in Poland European Journal of Clinical Microbiology & Infectious Diseases, April 5, 2013 Clinical Article
138 Resistance analysis of hepatitis C virus genotype 1 prior treatment null responders receiving daclatasvir and asunaprevir Hepatology, April 5, 2013 Clinical Article
139 JNK signaling maintains the mesenchymal properties of multi-drug resistant human epidermoid carcinoma KB cells through snail and twist1 Full Text BMC Cancer, April 5, 2013 Clinical Article
140 Epidemiological Interpretation of Studies Examining the Effect of Antibiotic Usage on Resistance Clinical Microbiology Reviews, April 4, 2013 Clinical Article
1 Carbapenem-resistant Enterobacteriaceae: A menace to our most vulnerable patients Cleveland Clinic Journal of Medicine, April 11, 2013 Free full text
2 Genetic diversity and antibiotic resistance in Escherichia coli from environmental surface water in Dhaka City, Bangladesh Diagnostic Microbiology and Infectious Disease, April 1, 2013 Review Article
3 Phase II study assessing lapatinib added to letrozole in patients with progressive disease under aromatase inhibitor in metastatic breast cancer--Study BES 06 Targeted Oncology, April 23, 2013
4 Signaling cross-talk in the resistance to HER family receptor targeted therapy Oncogene, April 2, 2013
5 Activities of Vancomycin-Containing Regimens against Colistin-Resistant Acinetobacter baumannii Clinical Strains Antimicrobial Agents and Chemotherapy, April 17, 2013
6 Effect of quercetin on the transport of N-acetyl 5-aminosalicylic acid Journal of Pharmacy and Pharmacology, April 10, 2013 Review Article
7 Levodopa-Resistant Freezing of Gait and Executive Dysfunction in Parkinsons Disease European Neurology, March 18, 2013
8 Apigenin sensitizes doxorubicin-resistant hepatocellular carcinoma BEL-7402/ADM cells to doxorubicin via inhibiting PI3K/Akt/Nrf2 pathway Carcinogenesis, April 8, 2013
9 Telavancin and Daptomycin activity against methicillin-resistant Staphylococcus aureus strains after vancomycin resistance selection in vitro Journal of Medical Microbiology, April 22, 2013
10 Epidemiological Interpretation of Studies Examining the Effect of Antibiotic Usage on Resistance Clinical Microbiology Reviews, April 4, 2013
11 The Economic Burden of Treatment-Resistant Depression Clinical Therapeutics, April 19, 2013
12 Multi-drug inhibition of the HER pathway in metastatic colorectal cancer: Results of a phase I study of pertuzumab plus cetuximab in cetuximab-refractory patients Investigational New Drugs, April 10, 2013
Indexed Journals in Pharmacy: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close